Catalyst Pharmaceuticals Inc (CPRX)
14.71
-0.31
(-2.06%)
USD |
NASDAQ |
May 03, 16:00
14.71
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Free Cash Flow: 61.86M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 61.86M |
| September 30, 2023 | 48.60M |
| June 30, 2023 | 124.13M |
| March 31, 2023 | 119.54M |
| December 31, 2022 | 116.02M |
| September 30, 2022 | 95.08M |
| June 30, 2022 | 75.41M |
| March 31, 2022 | 64.93M |
| December 31, 2021 | 59.35M |
| September 30, 2021 | 53.32M |
| June 30, 2021 | 43.12M |
| March 31, 2021 | 40.71M |
| December 31, 2020 | 45.02M |
| September 30, 2020 | 44.21M |
| June 30, 2020 | 49.03M |
| March 31, 2020 | 49.83M |
| December 31, 2019 | 34.59M |
| September 30, 2019 | 13.89M |
| June 30, 2019 | -9.346M |
| March 31, 2019 | -28.18M |
| December 31, 2018 | -26.24M |
| September 30, 2018 | -21.86M |
| June 30, 2018 | -17.52M |
| March 31, 2018 | -15.95M |
| December 31, 2017 | -13.74M |
| Date | Value |
|---|---|
| September 30, 2017 | -14.13M |
| June 30, 2017 | -14.78M |
| March 31, 2017 | -16.01M |
| December 31, 2016 | -18.06M |
| September 30, 2016 | -18.27M |
| June 30, 2016 | -20.35M |
| March 31, 2016 | -20.17M |
| December 31, 2015 | -18.04M |
| September 30, 2015 | -17.40M |
| June 30, 2015 | -15.61M |
| March 31, 2015 | -14.36M |
| December 31, 2014 | -13.00M |
| September 30, 2014 | -13.14M |
| June 30, 2014 | -11.25M |
| March 31, 2014 | -10.07M |
| December 31, 2013 | -9.885M |
| September 30, 2013 | -7.394M |
| June 30, 2013 | -6.811M |
| March 31, 2013 | -6.145M |
| December 31, 2012 | -5.193M |
| September 30, 2012 | -4.994M |
| June 30, 2012 | -5.145M |
| March 31, 2012 | -5.464M |
| December 31, 2011 | -4.989M |
| September 30, 2011 | -4.318M |
Free Cash Flow Range, Past 5 Years
-9.346M
Minimum
Jun 2019
124.13M
Maximum
Jun 2023
59.44M
Average
49.83M
Median
Mar 2020
Free Cash Flow Benchmarks
| Pfizer Inc | 4.793B |
| Sarepta Therapeutics Inc | -653.88M |
| PTC Therapeutics Inc | -199.47M |
| Corcept Therapeutics Inc | 126.90M |
| Cytokinetics Inc | -415.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 55.65M |
| Cash from Investing (Quarterly) | -38.32M |
| Cash from Financing (Quarterly) | -0.665M |
| Free Cash Flow Per Share (Quarterly) | 0.4688 |
| Free Cash Flow to Equity (Quarterly) | 53.33M |
| Free Cash Flow to Firm (Quarterly) | 53.33M |
| Free Cash Flow Yield | 3.75% |